FDA Approves First Prescription Digital Therapy for Major Depression

THURSDAY, April 4, 2024-- The U.S. Food and Drug Administration (FDA) has cleared the first prescription digital therapeutic authorized for the adjunctive treatment of major depressive disorder (MDD) symptoms.The approval is for Rejoyn, a six-week...